Concepedia

Publication | Open Access

Pharmacokinetics and safety of letermovir, a novel anti‐human cytomegalovirus drug, in patients with renal impairment

DOIFull Paper Access

36

Citations

20

References

2017

Year

Dirk Kropeit, Jürgen Scheuenpflug, Katharina Erb‐Zohar, Atef Halabi, Hans‐Peter Stobernack, Ellen G. J. Hulskotte, Arne van Schanke, Holger Zimmermann, Helga Rübsamen‐Schaeff
British Journal of Clinical Pharmacology

Abstract

Renal impairment increased exposure to letermovir, although age was a confounding factor.

References

YearCitations

Page 1